IPO Boutique

Ra Medical Systems, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Ra Medical Systems, Inc. , and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Ra Medical Systems, Inc. RMED -
NYSE
$14.00-$16.00 $17.00 $21.503.9 million9/27/2018
Piper Jaffray, Cantor
Co-Manager(s):
SunTrust Robinson Humphrey, Nomura, Maxim Group
Health Care
Filing(s):

Filed 2018-07-16
Underwriters Added 2018-08-24
Terms Added 2018-09-17



Ra Medical Systems, Inc. Quote & Chart - Click for current quote - RMED

About Ra Medical Systems, Inc. (adapted from Ra Medical Systems, Inc. prospectus):
They are a commercial-stage medical device company leveraging their advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "RMED" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved